Pyrazinecarbonitrile CAS: 19847-12-2

CAS NO: 19847-12-2
Pyrazinecarbonitrile
Chemical Name: Pyrazinecarbonitrile
Molecular Formula: C5H3N3
Formula Weight: 105.1
CAS No.: 19847-12-2
Description Review
Description

Pyrazinecarbonitrile (CAS: 19847-12-2) is an organic compound that is used for a variety of purposes, including in the synthesis of pharmaceuticals, agrochemicals, and other industrial products. It has unique chemical properties that make it useful in these applications, and it is widely used in research and development. In this article, we will explore the molecular details of Pyrazinecarbonitrile, its potential benefits, mechanism, safety, and side effects.

Chemical Name:

Pyrazinecarbonitrile

Molecular Formula:

C5H3N3

Formula Weight:

105.1 g/mol

CAS No:

19847-12-2

Top Ten Keywords and Synonyms:

  1. Pyrazinecarbonitrile
  2. CAS number 19847-12-2
  3. Organic compound
  4. Pharmaceutical synthesis
  5. Agrochemicals
  6. Molecular formula C5H3N3
  7. 2-Cyanopyrazine
  8. 2-Pyrazinecarbonitrile
  9. Chemical synthesis
  10. Nitrogen-containing heterocyclic compound

Health Benefits of Pyrazinecarbonitrile:

Pyrazinecarbonitrile does not have any established health benefits as it is primarily an industrial chemical used in the production of various products, including pharmaceuticals and agrochemicals.

Potential Effects of Pyrazinecarbonitrile:

Pyrazinecarbonitrile has unique chemical properties that make it useful in various industrial applications, including pharmaceutical synthesis, agrochemicals, and other industrial products. Its key properties include its ability to act as a versatile building block in the synthesis of other compounds, its low solubility, and its thermal stability. It can be used to synthesize a variety of nitrogen-containing heterocyclic compounds, which are important in pharmaceuticals and other applications.

Product Mechanism:

The exact mechanism by which Pyrazinecarbonitrile works is not well understood, as it is primarily used as a building block in the synthesis of other compounds. However, Pyrazinecarbonitrile is known to be a key component in the production of nitrogen-containing heterocyclic compounds, which have a wide variety of uses in pharmaceuticals and other applications.

Safety:

Pyrazinecarbonitrile is not known to be particularly hazardous to human health, but care should still be taken when handling and using this compound. It is known to be an irritant to the skin and eyes, and should be handled with appropriate protective equipment, such as gloves and goggles. It is also flammable, and should be stored and used in a well-ventilated area.

Side Effects:

Pyrazinecarbonitrile is not known to cause any significant side effects, as it is primarily used in industrial applications and is not intended for human consumption. However, exposure to this compound can cause skin and eye irritation, as well as respiratory problems if it is inhaled.

Dosing Information:

Because Pyrazinecarbonitrile is primarily used as a building block in the synthesis of other compounds, there is no standard dosing regimen for this compound. The appropriate dose and administration regimen will depend on the specific application and the desired endpoint.

Conclusion:

Pyrazinecarbonitrile is an organic compound that is used for a variety of purposes, including in the synthesis of pharmaceuticals, agrochemicals, and other industrial products. Its key properties, including its versatility as a building block and its low solubility and thermal stability make it a valuable tool in chemical synthesis. While Pyrazinecarbonitrile is not known to pose significant health risks, care should be taken when handling and using this compound to avoid skin and eye irritation and respiratory problems. Overall, Pyrazinecarbonitrile is an important component in the production of various industrial products, and is likely to continue to play a valuable role in chemical synthesis and industrial processes in the future

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code